- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04829877
Trajectory of Psychological Distress Among Infertility Women
Trajectory of Psychological Distress Among Infertility Women: Efficacy and Mechanism of Mind-body Intervention With Heart Rate Variability Biofeedback
Background: Infertility is a serious reproductive health issue and affects 48.5 million couples worldwide. Women undergoing fertility treatment often experienced psychological distress but also social stigma that is close linked to later pregnancy outcome. Despite the advancement in assisted reproductive technology, effective interventions for reducing stress, anxiety, and depressive symptoms for infertility women remain lacking.
Objectives: The objective of this proposal is to evaluate the efficacy of web-based mind-body intervention combining HRV biofeedback on the infertility women's anxiety symptoms, levels of depression, HRV function, mindful awareness, infertility self-efficacy, and pregnancy rates.
Methods: We plan to conduct a randomized controlled trial on the web-based mind-body intervention combining heart rate variability biofeedback. Eligible women will be recruited and randomized into three groups. Intention-to-treat analysis and mixed regression modeling will be used to estimate the effectiveness of the interventions.
Anticipatory results: Effective strategies will be determined for infertility women.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taipei, Taiwan, 110
- Recruiting
- Infertility clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 20-year-old and above
- Seeking infertility care
- Contemplating pregnancy
- Intended to start their ART cycle
- Able to speak Taiwanese or Mandarin
Exclusion Criteria:
- Diagnosis of cardiovascular disease, depressive disorder, anxiety disorder, cardiac arrhythmia
- Already had started their ART treatment
- Taking medications that might affect ANS activity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Web-based mind-body intervention with HRVB
Both standard usual care and the web-based mind-body intervention with HRV biofeedback (MBI-HRVB) will be provided to the participants.
The web-based mind-body intervention with HRV biofeedback program consisted of 5-week training sessions and breathing training.
|
The web-based mind-body intervention with HRVB contains the following components: 1) Breathing training with HRV biofeedback; 2) 5 different topics will be included ; 3) Home exercise of slow breathing and mindfulness exercise.
|
Experimental: Web-based mind-body intervention
Both standard usual care and the web-based mind-body intervention will be provided to the participants.
The web-based mind-body intervention program consisted of 5-week training sessions.
|
The web-based mind-body intervention will receive 5 different topics courses.
|
No Intervention: Control
The women in the control group will receive the standard usual care provided at the fertility clinic.
The standard care protocols encompass elements such as routine assessment and health education at each visit.
Participants enrolled in the control group will be approached once a week by a nurse to provide health consultation about fertility treatment, medication, signs, and symptoms of discomfort for five weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anxiety
Time Frame: Baseline
|
Anxiety symptoms will be assessed using the Taiwanese version of the State Anxiety Inventory (SAI).
|
Baseline
|
Anxiety
Time Frame: 1 week post-intervention
|
Anxiety symptoms will be assessed using the Taiwanese version of the State Anxiety Inventory (SAI).
|
1 week post-intervention
|
Anxiety
Time Frame: 1 month post-intervention
|
Anxiety symptoms will be assessed using the Taiwanese version of the State Anxiety Inventory (SAI).
|
1 month post-intervention
|
Anxiety
Time Frame: 2 month post-intervention
|
Anxiety symptoms will be assessed using the Taiwanese version of the State Anxiety Inventory (SAI).
|
2 month post-intervention
|
Anxiety
Time Frame: 3 month post-intervention
|
Anxiety symptoms will be assessed using the Taiwanese version of the State Anxiety Inventory (SAI).
|
3 month post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Depressive symptoms
Time Frame: Baseline, post-intervention 1 week, month 1 , 2 and 3
|
The Taiwanese version of the Beck Depression Inventory (BDI) will be used to assess depressive symptoms among infertility women.
|
Baseline, post-intervention 1 week, month 1 , 2 and 3
|
HRV function
Time Frame: Baseline, post-intervention 1 week, month 1 , 2 and 3
|
The HRV signal will be measured using standard equipment.
|
Baseline, post-intervention 1 week, month 1 , 2 and 3
|
Mindful awareness
Time Frame: Baseline, post-intervention 1 week, month 1 , 2 and 3
|
The Taiwanese version of the Five Facet Mindfulness Questionnaire (FFMQ) will be adopted to assess levels of mindfulness.
|
Baseline, post-intervention 1 week, month 1 , 2 and 3
|
Infertility self-efficacy
Time Frame: Baseline, post-intervention 1 week, month 1 , 2 and 3
|
The infertility Self-Efficacy Scale (ISE) will be used for studied women.
|
Baseline, post-intervention 1 week, month 1 , 2 and 3
|
Pregnancy rates
Time Frame: 15 days after embryo transfer or ultrasound
|
Clinical pregnancy will be defined as a positive blood, urinary pregnancy test.
|
15 days after embryo transfer or ultrasound
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- N201807030
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Istanbul University - Cerrahpasa (IUC)RecruitingInfertility | Sexual Dysfunction | Infertility, Male | Nurse's Role | Sexuality | Infertility; FemaleTurkey
Clinical Trials on Web-based mind-body intervention with HRVB
-
Mercy Medical CenterCompleted
-
University of AlbertaCompletedPrimary Biliary CirrhosisCanada
-
Cardenal Herrera UniversityCompleted
-
Beth Israel Deaconess Medical CenterRecruiting
-
Beth Israel Deaconess Medical CenterCompletedChronic Pain | Chronic Pain SyndromeUnited States
-
Tel-Aviv Sourasky Medical CenterUnknownElderly | Treatment
-
University of Sao Paulo General HospitalEnrolling by invitationCompulsive Sexual BehaviorBrazil
-
Massachusetts General HospitalHarvard Medical School (HMS and HSDM)Not yet recruitingColorectal Cancer | Sexual Dysfunction | Anal Cancer
-
Beth Israel Deaconess Medical CenterNot yet recruitingLong COVID | COVID Long-Haul | Post-Acute Sequelae of COVID-19
-
Michigan State UniversityNational Center for Complementary and Integrative Health (NCCIH)RecruitingChildren's Mental, Emotional, Behavioral, and Physical HealthUnited States